$SKWD

Skyward Specialty Insurance Group reported Q2 2026 combined ratio of 89.5% and diluted operating EPS of $1.30, up 46% YoY. Gross written premiums rose 13.3% to $740.6M pro forma, with net written premiums at $485.6M. Management grew agriculture and A&H while reducing property and captives; Apollo acquisition closed Jan 1. Book value per share rose to $28.55 and it repurchased 223k shares for $9.7M.

Skyward Specialty Insurance (NASDAQ:SKWD) reported Q2 CY2026 revenue of $489.5 million, up 53% year on year and 4.4% above Wall Street estimates. Non-GAAP earnings were $1.30 per share, 10.8% above consensus. The article also cites BVPS rising from $18.05 to $28.55 over two years and shares down 2.7% to $59.86 after results.

Skyward Specialty Insurance Group, Inc. (SKWD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsrelease-ex9912q2026.htm EX-99.1 Document Exhibit 99.1 Skyward Group Reports Second Quarter 2026 Results Houston, TX – August 4, 2026 – Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Group” or the “Company”) today reported second quarter 2026 re

Skyward Specialty Insurance (NASDAQ: SKWD) is set to report Q2 results Tuesday after the bell. The company’s prior quarter revenue was $475.9 million, up 44.8% year over year. For Q2, analysts expect revenue growth of 46.6% YoY. The average analyst price target is $65.18 versus about $60 currently.

Sixfold, a New York AI underwriting firm, launched its “AI Underwriter” for property and casualty insurers on June 15, aiming to move submissions to quote- and bind-ready status with human sign-off. The company says testing at Skyward Specialty helped improve processing and underwriting metrics. Skyward reported $667.7m gross written premiums and a 89.5% combined ratio in 1Q 2026.

Schmitt Thomas N (CPO, Skyward Group) sold 8,397 shares of Skyward Specialty Insurance Group, Inc. (SKWD) at $51.32 ($0.43M total) on 2026-06-12.

A recent StockStory analysis reveals Wall Street's divided opinions on three stocks, with a buy recommendation for Skyward Specialty Insurance (SKWD) and sell signals for Transcat (TRNS) and Purple (PRPL). While analysts generally project significant upside, sell ratings are rare due to potential conflicts of interest. The report outlines specific financial concerns for TRNS and PRPL, contrasting them with SKWD's strong performance indicators.

Skyward Specialty Insurance Group, Inc. (SKWD) reported strong first-quarter 2026 results, with operating earnings per share increasing 38.9% year-over-year and beating analyst estimates. Total revenues surged 44.8%, driven by stronger premiums, improved underwriting results, and the accretive impact of its Apollo acquisition. The company's premium base expanded across both its Skyward Specialty and Apollo segments, with a notable decrease in its combined ratio, indicating improved profitability.

This article examines how Skyward protects itself from pricing pressures and economic cycles by focusing on niche market strategies. The content of the article is not available to provide further details.

American Century Companies Inc. has increased its stake in Skyward Specialty Insurance Group Inc. (NASDAQ:SKWD) by 9.2%, acquiring an additional 55,361 shares, bringing its total to 654,123 shares valued at over $31 million. Other institutional investors like Vanguard and Invesco also boosted their positions, with 94.83% of SKWD stock now held by institutions. Skyward Specialty recently reported strong quarterly earnings, beating analyst expectations, and has an average "Moderate Buy" rating with a target price of $65.80.